Works matching DE "IMMUNOSUPPRESSION"

Results: 5000

SARS.

Published in:

Hemodialysis International, 2004, v. 8, n. 1, p. 88, doi. 10.1111/j.1492-7535.2004.0085x.x

By:

Ignacio, C.;
Jayoma, M.

Publication type:

Article

Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells.

Published in:

OncoImmunology, 2015, v. 4, n. 7, p. N.PAG, doi. 10.1080/2162402X.2015.1016700

By:

Wu, Annie A;
Drake, Virginia;
Huang, Huai-Shiuan;
Chiu, ShihChi;
Zheng, Lei

Publication type:

Article

CD14 macrophage-like cells as the linchpin of cervical cancer perpetrated immune suppression and early metastatic spread: A new therapeutic lead?

Published in:

OncoImmunology, 2015, v. 4, n. 6, p. 0, doi. 10.1080/2162402X.2015.1009296

By:

Heeren, A Marijne;
Kenter, Gemma G;
Jordanova, Ekaterina S;
de Gruijl, Tanja D

Publication type:

Article

Tumor-infiltrating plasmacytoid dendritic cells promote immunosuppression by Tr1 cells in human liver tumors.

Published in:

OncoImmunology, 2015, v. 4, n. 6, p. 0, doi. 10.1080/2162402X.2015.1008355

By:

Pedroza-Gonzalez, Alexander;
Zhou, Guoying;
Vargas-Mendez, Ernesto;
Boor, Patrick PC;
Mancham, Shanta;
Verhoef, Cornelis;
Polak, Wojciech G;
Grünhagen, Dirk;
Pan, Qiuwei;
Janssen, Harry LA;
Garcia-Romo, Gina S;
Biermann, Katharina;
Tjwa, Eric TTL;
IJzermans, Jan NM;
Kwekkeboom, Jaap;
Sprengers, Dave

Publication type:

Article

CD39: A complementary target to immune checkpoints to counteract tumor-mediated immunosuppression.

Published in:

OncoImmunology, 2015, v. 4, n. 5, p. 0, doi. 10.1080/2162402X.2014.1003015

By:

Bonnefoy, Nathalie;
Bastid, Jérémy;
Alberici, Gilles;
Bensussan, Armand;
Eliaou, Jean-François

Publication type:

Article

The mutually regulatory loop of epithelial–mesenchymal transition and immunosuppression in cancer progression.

Published in:

OncoImmunology, 2015, v. 4, n. 5, p. 0, doi. 10.1080/2162402X.2014.1002731

By:

Chen, Limo;
Heymach, John V;
Qin, F Xiao-Feng;
Gibbons, Don L

Publication type:

Article

Characterization of myeloid leukocytes and soluble mediators in pancreatic cancer: importance of myeloid-derived suppressor cells.

Published in:

OncoImmunology, 2015, v. 4, n. 4, p. 00, doi. 10.1080/2162402X.2014.998519

By:

Karakhanova, Svetlana;
Link, Julia;
Heinrich, Moritz;
Hassenpflug, Matthias;
Bunge, Henriette;
von Ahn, Katharina;
Brecht, Ramona;
Mathes, Andreas;
Maier, Caroline;
Shevchenko, Ivan;
Yang, Yuhui;
Umansky, Viktor;
Werner, Jens;
Bazhin, Alexandr V

Publication type:

Article

Mast cell/MDSC a liaison immunosuppressive for tumor microenvironment.

Published in:

OncoImmunology, 2015, v. 4, n. 4, p. 00, doi. 10.1080/2162402X.2014.1001232

By:

Frossi, Barbara;
Pucillo, Carlo E;
Danelli, Luca

Publication type:

Article

Characterization of the myeloid-derived suppressor cell subset regulated by NK cells in malignant lymphoma.

Published in:

OncoImmunology, 2015, v. 4, n. 3, p. 00, doi. 10.1080/2162402X.2014.995541

By:

Sato, Yusuke;
Shimizu, Kanako;
Shinga, Jun;
Hidaka, Michihiro;
Kawano, Fumio;
Kakimi, Kazuhiro;
Yamasaki, Satoru;
Asakura, Miki;
Fujii, Shin-ichiro

Publication type:

Article

miR-23a blockade enhances adoptive T cell transfer therapy by preserving immune-competence in the tumor microenvironment.

Published in:

OncoImmunology, 2015, v. 4, n. 3, p. 00, doi. 10.4161/2162402X.2014.990803

By:

Lin, Regina;
Sampson, John H;
Li, Qi-Jing;
Zhu, Bo

Publication type:

Article

Sunitinib depletes myeloid-derived suppressor cells and synergizes with a cancer vaccine to enhance antigen-specific immune responses and tumor eradication.

Published in:

OncoImmunology, 2015, v. 4, n. 3, p. 00, doi. 10.4161/2162402X.2014.989764

By:

Draghiciu, Oana;
Nijman, Hans W;
Hoogeboom, Baukje Nynke;
Meijerhof, Tjarko;
Daemen, Toos

Publication type:

Article

Author's view: radiation and immunotherapy as systemic therapy for solid tumors.

Published in:

OncoImmunology, 2015, v. 4, n. 3, p. 00, doi. 10.4161/2162402X.2014.986402

By:

Seyedin, Steven N.;
Tang, Chad;
Welsh, James W

Publication type:

Article

Characterization of the in vivo immune network of IDO, tryptophan metabolism, PD-L1, and CTLA-4 in circulating immune cells in melanoma.

Published in:

OncoImmunology, 2015, v. 4, n. 3, p. 00, doi. 10.4161/2162402X.2014.982382

By:

Chevolet, I;
Speeckaert, R;
Schreuer, M;
Neyns, B;
Krysko, O;
Bachert, C;
Hennart, B;
Allorge, D;
van Geel, N;
Van Gele, M;
Brochez, L

Publication type:

Article

The ins and outs of osteopontin.

Published in:

OncoImmunology, 2015, v. 4, n. 3, p. 00, doi. 10.4161/2162402X.2014.978711

By:

Chiodoni, Claudia;
Sangaletti, Sabina;
Tripodo, Claudio;
Colombo, Mario P

Publication type:

Article

Targeting hypoxia at the forefront of anticancer immune responses.

Published in:

OncoImmunology, 2014, v. 3, n. 12, p. N.PAG, doi. 10.4161/21624011.2014.954463

By:

Noman, Muhammad Zaeem;
Chouaib, Salem

Publication type:

Article

Lymphocyte activation gene-3 (LAG-3, CD223) in plasmacytoid dendritic cells (pDCs): a molecular target for the restoration of active antitumor immunity.

Published in:

OncoImmunology, 2014, v. 3, n. 11, p. N.PAG, doi. 10.4161/21624011.2014.967146

By:

Castelli, Chiara;
Triebel, Frédéric;
Rivoltini, Licia;
Camisaschi, Chiara

Publication type:

Article

Differential potency of regulatory T cell-mediated immunosuppression in kidney tumors compared to subcutaneous tumors.

Published in:

OncoImmunology, 2014, v. 3, n. 11, p. N.PAG, doi. 10.4161/21624011.2014.963395

By:

Devaud, Christel;
Westwood, Jennifer A.;
Teng, Michele W. L.;
John, Liza B.;
Yong, Carmen S. M.;
Duong, Connie P. M.;
Smyth, Mark J.;
Darcy, Phillip K.;
Kershaw, Michael H.

Publication type:

Article

Co-blockade of immune checkpoints and adenosine A 2A receptor suppresses metastasis.

Published in:

OncoImmunology, 2014, v. 3, n. 10, p. N.PAG, doi. 10.4161/21624011.2014.958952

By:

Young, Arabella;
Mittal, Deepak;
Stannard, Kimberley;
Yong, Michelle;
Teng, Michele WL;
Allard, Bertrand;
Stagg, John;
Smyth, Mark J

Publication type:

Article

Overcoming immunosuppression to enhance a p53MVA vaccine.

Published in:

OncoImmunology, 2014, v. 3, n. 10, p. N.PAG, doi. 10.4161/21624011.2014.958949

By:

Hardwick, Nicola;
Chung, Vincent;
Cristea, Mihaela;
Ellenhorn, Joshua DI;
Diamond, Don J

Publication type:

Article

Local treatment of a pleural mesothelioma tumor with ONCOS-102 induces a systemic antitumor CD8 T-cell response, prominent infiltration of CD8 lymphocytes and Th1 type polarization.

Published in:

OncoImmunology, 2014, v. 3, n. 10, p. N.PAG, doi. 10.4161/21624011.2014.958937

By:

Ranki, Tuuli;
Joensuu, Timo;
Jäger, Elke;
Karbach, Julia;
Wahle, Claudia;
Kairemo, Kalevi;
Alanko, Tuomo;
Partanen, Kaarina;
Turkki, Riku;
Linder, Nina;
Lundin, Johan;
Ristimäki, Ari;
Kankainen, Matti;
Hemminki, Akseli;
Backman, Charlotta;
Dienel, Kasper;
von Euler, Mikael;
Haavisto, Elina;
Hakonen, Tiina;
Juhila, Juuso

Publication type:

Article

Location, location, location: functional and phenotypic heterogeneity between tumor-infiltrating and non-infiltrating myeloid-derived suppressor cells.

Published in:

OncoImmunology, 2014, v. 3, n. 10, p. N.PAG, doi. 10.4161/21624011.2014.956579

By:

Maenhout, Sarah K;
Thielemans, Kris;
Aerts, Joeri L

Publication type:

Article

Tumor stroma-derived factors skew monocyte to dendritic cell differentiation toward a suppressive CD14 PD-L1 phenotype in prostate cancer.

Published in:

OncoImmunology, 2014, v. 3, n. 9, p. N.PAG, doi. 10.4161/21624011.2014.955331

By:

Spary, Lisa K;
Salimu, Josephine;
Webber, Jason P;
Clayton, Aled;
Mason, Malcolm D;
Tabi, Zsuzsanna

Publication type:

Article

New insights into androgenic immune regulation.

Published in:

OncoImmunology, 2014, v. 3, n. 9, p. N.PAG, doi. 10.4161/21624011.2014.954968

By:

Arredouani, Mohamed Simo

Publication type:

Article

Innate γδT17 cells convert cancer-elicited inflammation into immunosuppression through myeloid-derived suppressor cells.

Published in:

OncoImmunology, 2014, v. 3, n. 8, p. N.PAG, doi. 10.4161/21624011.2014.953423

By:

Yan, Jun;
Huang, Jian

Publication type:

Article

Breaking the vicious cycle between breast cancer cells and tumor-associated macrophages.

Published in:

OncoImmunology, 2014, v. 3, n. 8, p. N.PAG, doi. 10.4161/21624011.2014.953418

By:

Su, Shicheng;
Wu, Wei;
He, Chonghua;
Liu, Qiang;
Song, Erwei

Publication type:

Article

Spontaneous presence of FOXO3-specific T cells in cancer patients.

Published in:

OncoImmunology, 2014, v. 3, n. 8, p. N.PAG, doi. 10.4161/21624011.2014.953411

By:

Larsen, Stine Kiaer;
Ahmad, Shamaila Munir;
Idorn, Manja;
Met, Özcan;
Martinenaite, Evelina;
Svane, Inge Marie;
Straten, Per thor;
Andersen, Mads Hald

Publication type:

Article

Ménage à trois.

Published in:

OncoImmunology, 2014, v. 3, n. 5, p. N.PAG, doi. 10.4161/onci.28927

By:

Wainwright, Derek A;
Lesniak, Maciej S

Publication type:

Article

Myeloid-derived suppressor cells link inflammation to cancer.

Published in:

OncoImmunology, 2014, v. 3, n. 5, p. N.PAG, doi. 10.4161/onci.28581

By:

Wang, Dingzhi;
DuBois, Raymond N

Publication type:

Article

Rethinking the role of myeloid-derived suppressor cells in adoptive T-cell therapy for cancer.

Published in:

OncoImmunology, 2014, v. 3, n. 4, p. N.PAG, doi. 10.4161/onci.28464

By:

Arina, Ainhoa

Publication type:

Article

Two is better than one: Complementing oncolytic virotherapy with gemcitabine to potentiate antitumor immune responses.

Published in:

OncoImmunology, 2014, v. 3, n. 2, p. N.PAG, doi. 10.4161/onci.27622

By:

Gujar, Shashi;
Clements, Derek;
Lee, Patrick W.K.

Publication type:

Article

Intratumoral checkpoint subversion as a strategy for minimizing adverse effects.

Published in:

2014

By:

Alabanza, Leah;
Gnjatic, Sacha;
Bhardwaj, Nina;
Brody, Joshua

Publication type:

Editorial

The dual targeting of immunosuppressive cells and oxidants promotes effector and memory T-cell functions against lung cancer.

Published in:

OncoImmunology, 2014, v. 3, n. 1, p. N.PAG, doi. 10.4161/onci.27401

By:

Sawant, Anandi;
Schafer, Cara C;
Ponnazhagan, Selvarangan;
Deshane, Jessy S

Publication type:

Article

Blockade of PD-1 immunosuppression boosts CAR T-cell therapy.

Published in:

OncoImmunology, 2013, v. 2, n. 10, p. e26286-1, doi. 10.4161/onci.26286

By:

John, Liza B.;
Kershaw, Michael H.;
Darcy, Phillip K.

Publication type:

Article

HLA-DR expression on myeloid cells is a potential prognostic factor in patients with high-risk neuroblastoma.

Published in:

OncoImmunology, 2013, v. 2, n. 10, p. e26616-1, doi. 10.4161/onci.26616

By:

Gowda, Madhu;
Payne, Kyle K.;
Godder, Kamar;
Manjili, Masoud H.

Publication type:

Article

Overcoming immunosuppression as a new immunotherapeutic approach against pancreatic cancer.

Published in:

OncoImmunology, 2013, v. 2, n. 9, p. e25736-1, doi. 10.4161/onci.25736

By:

Bazhin, Alexandr V.;
Bayry, Jagadeesh;
Umansky, Viktor;
Werner, Jens;
Karakhanova, Svetlana

Publication type:

Article

Contribution of regulatory T cells to immunosuppression and disease progression in multiple myeloma patients.

Published in:

OncoImmunology, 2013, v. 2, n. 9, p. e25619-1, doi. 10.4161/onci.25619

By:

raja, Karthick raja Muthu;
hajek, Roman

Publication type:

Article

Early onset and enhanced growth of autochthonous mammary carcinomas in C3-deficient Her2/neu transgenic mice.

Published in:

OncoImmunology, 2013, v. 2, n. 9, p. e26137-1, doi. 10.4161/onci.26137

By:

Bandini, Silvio;
Curcio, Claudia;
Macagno, Marco;
Quaglino, Elena;
Arigoni, Maddalena;
Lanzardo, Stefania;
Hysi, Albana;
Barutello, Giuseppina;
Consolino, Lorena;
Longo, Dario Livio;
Musiani, Piero;
Forni, Guido;
Iezzi, Manuela;
Cavallo, Federica

Publication type:

Article

Pancreatic cancer-associated stellate cells: A viable target for reducing immunosuppression in the tumor microenvironment.

Published in:

OncoImmunology, 2013, v. 2, n. 7, p. e24891-1, doi. 10.4161/onci.24891

By:

Mace, Thomas A.;
Bloomston, Mark;
Lesinski, Gregory B.

Publication type:

Article

High immunosuppressive burden in advanced hepatocellular carcinoma patients: Can effector functions be restored?

Published in:

OncoImmunology, 2013, v. 2, n. 7, p. e24679-1, doi. 10.4161/onci.24679

By:

Lugade, Amit A.;
Kalathil, Suresh;
Miller, Austin;
Iyer, Renuka;
Thanavala, Yasmin

Publication type:

Article

Trial watch.

Published in:

OncoImmunology, 2013, v. 2, n. 6, p. e24612-1, doi. 10.4161/onci.24612

By:

Vacchelli, Erika;
Eggermont, Alexander;
Sautès-Fridman, Catherine;
Galon, Jérôme;
Zitvogel, Laurence;
Kroemer, Guido;
Galluzzi, Lorenzo

Publication type:

Article

Trial Watch: Adoptive cell transfer for anticancer immunotherapy.

Published in:

OncoImmunology, 2013, v. 2, n. 5, p. e24238-1, doi. 10.4161/onci.24238

By:

Vacchelli, Erika;
Eggermont, Alexander;
Fridman, Wolf Hervé;
Galon, Jérôme;
Tartour, Eric;
Zitvogel, Laurence;
Kroemer, Guido;
Galluzzi, Lorenzo

Publication type:

Article

Breaking tumor-induced immunosuppression with 5'-triphosphate siRNA silencing TGFβ and activating RIG-I.

Published in:

OncoImmunology, 2013, v. 2, n. 5, p. e24170-1, doi. 10.4161/onci.24170

By:

Schnurr, Max;
Duewell, Peter

Publication type:

Article

Balance is a key for happiness.

Published in:

OncoImmunology, 2013, v. 2, n. 5, p. e24211-1, doi. 10.4161/onci.24211

By:

Izhak, Liat;
Berzofsky, Jay A.;
Terabe, Masaki

Publication type:

Article

Thwarting galectin-induced immunosuppression in breast cancer.

Published in:

OncoImmunology, 2013, v. 2, n. 5, p. e24077-1, doi. 10.4161/onci.24077

By:

Salatino, Mariana;
Dalotto-Moreno, Tomas;
Rabinovich, Gabriel A.

Publication type:

Article

Myeloid-derived suppressor cells as a novel target for the control of osteolytic bone disease.

Published in:

OncoImmunology, 2013, v. 2, n. 5, p. e24064-1, doi. 10.4161/onci.24064

By:

Sawant, Anandi;
Ponnazhagan, Selvarangan

Publication type:

Article

Indoleamine 2,3-dioxygenase activity and clinical outcome following induction chemotherapy and concurrent chemoradiation in Stage III non-small cell lung cancer.

Published in:

OncoImmunology, 2013, v. 2, n. 3, p. e23428-1, doi. 10.4161/onci.23428

By:

Creelan, Ben C.;
Antonia, Scott;
Bepler, Gerold;
Garrett, Timothy J.;
Simon, George R.;
Soliman, Hatem H.

Publication type:

Article

Neuropilin 1 guides regulatory T cells into VEGF-producing melanoma.

Published in:

OncoImmunology, 2013, v. 2, n. 2, p. e23039-1, doi. 10.4161/onci.23039

By:

Hansen, Wiebke

Publication type:

Article

Retinoic acid-producing DCs and gut-tropic FOXP3<sup>+</sup> regulatory T cells in the induction of oral tolerance.

Published in:

OncoImmunology, 2013, v. 2, n. 2, p. e22987-1, doi. 10.4161/onci.22987

By:

Villablanca, Eduardo J.

Publication type:

Article

Forging a link between oncogenic signaling and immunosuppression in melanoma.

Published in:

OncoImmunology, 2013, v. 2, n. 2, p. e22745-1, doi. 10.4161/onci.22745

By:

Khalili, Jahan S.;
Hwu, Patrick;
Lizée, Gregory

Publication type:

Article

The role of soluble CD40L in immunosuppression.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22546-1, doi. 10.4161/onci.22546

By:

Schlom, Jeffrey;
Jochems, Caroline;
Gulley, James L.;
Huang, Jianping

Publication type:

Article